CBS 2019
CBSMD教育中心
English

急性冠脉综合征

科研文章

荐读文献

A Novel Circulating MicroRNA for the Detection of Acute Myocarditis Association of Silent Myocardial Infarction and Sudden Cardiac Death Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease Nonculprit Lesion Myocardial Infarction Following Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome Myocardial Infarction Risk Stratification With a Single Measurement of High-Sensitivity Troponin I Management of Myocardial Revascularization Failure: An Expert Consensus Document of the EAPCI Red Cell Distribution Width in Patients with Diabetes and Myocardial Infarction: an analysis from the EXAMINE trial Incidence and Outcomes of Acute Coronary Syndrome After Transcatheter Aortic Valve Replacement The (R)Evolution of the CICU - Better for the Patient, Better for Education Phosphoproteomic Analysis of Neonatal Regenerative Myocardium Revealed Important Roles of CHK1 via Activating mTORC1/P70S6K Pathway

Clinical Case Study2017 Dec 26;10(24):2528-2535.

JOURNAL:JACC Cardiovasc Interv. Article Link

Nonculprit Stenosis Evaluation Using Instantaneous Wave-Free Ratio in Patients With ST-Segment Elevation Myocardial Infarction

Thim T, Götberg M, Fröbert O et al. Keywords: FFR; complete primary revascularization; full revascularization; iFR; primary PCI

ABSTRACT


OBJECTIVES - The aim of this study was to examine the level of agreement between acute instantaneous wave-free ratio (iFR) measured across nonculprit stenoses in patients with ST-segment elevation myocardial infarction (STEMI) and iFR measured at a staged follow-up procedure.


BACKGROUND - Acute full revascularization of nonculprit stenoses in STEMI is debated and currently guided by angiography. Acute functional assessment of nonculprit stenoses may be considered.


METHODS - Immediately after successful primary culprit intervention for STEMI, nonculprit coronary stenoses were evaluated with iFR and left untreated. Follow-up evaluation with iFR was performed at a later stage. iFR <0.90 was considered hemodynamically significant.


RESULTS - One hundred twenty patients with 157 nonculprit lesions were included. Median acute iFR was 0.89 (interquartile range [IQR]: 0.82 to 0.94; n = 156), and median follow-up iFR was 0.91 (interquartile range: 0.86 to 0.96; n = 147). Classification agreement was 78% between acute and follow-up iFR. The negative predictive value of acute iFR was 89%. Median time from acute to follow-up evaluation was 16 days (IQR: 5 to 32 days). With follow-up within 5 days after STEMI, no difference was observed between acute and follow-up iFR, and classification agreement was 89%. With follow-up ≥16 days after STEMI, acute iFR was lower than follow-up iFR, and classification agreement was 70%.


CONCLUSIONS - Acute iFR evaluation appeared valid for ruling out significant nonculprit stenoses in patients with STEMI undergoing primary percutaneous coronary intervention. The time interval from acute to follow-up iFR influenced classification agreement, suggesting that inherent physiological disarrangements during STEMI may contribute to classification disagreement.


Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.